Invention Grant
US08088766B2 Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors
有权
氰基胍和氰酰胺作为ErbB2和EGFR抑制剂
- Patent Title: Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors
- Patent Title (中): 氰基胍和氰酰胺作为ErbB2和EGFR抑制剂
-
Application No.: US12209738Application Date: 2008-09-12
-
Publication No.: US08088766B2Publication Date: 2012-01-03
- Inventor: Eli Wallace , George Topolov , Qian Zhao , Joseph P. Lyssikatos
- Applicant: Eli Wallace , George Topolov , Qian Zhao , Joseph P. Lyssikatos
- Applicant Address: US CO Boulder
- Assignee: Array BioPharma Inc.
- Current Assignee: Array BioPharma Inc.
- Current Assignee Address: US CO Boulder
- Agency: Array BioPharma Inc.
- Agent John R. Moore; Corey M. Williams
- Main IPC: C07D239/94
- IPC: C07D239/94 ; C07D295/125 ; A61K31/517 ; A61K31/422 ; C07D215/44 ; A61K31/4706
Abstract:
Cyanoguanidine quinazoline and cyanoamidine quinazolamine derivatives that are useful in the treatment of hyperproliferative diseases are disclosed. Methods of treating hyperproliferative diseases in mammals are also disclosed.
Public/Granted literature
- US20090012290A1 CYANOGUANIDINES AND CYANOAMIDINES AS ERBB2 AND EGFR INHIBITORS Public/Granted day:2009-01-08
Information query
